Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Nov 21, 2024, 3:46 PM EST - Market closed
Edesa Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
Market Capitalization | 7 | 13 | 14 | 98 | 78 | 47 | |
Market Cap Growth | -17.55% | -6.42% | -85.44% | 26.16% | 65.89% | - | |
Enterprise Value | 5 | 7 | 1 | 90 | 75 | 40 | |
Last Close Price | 2.20 | 4.42 | 6.45 | 51.66 | 56.49 | 43.60 | |
Forward PE | - | - | 56.67 | - | - | - | |
PS Ratio | - | - | - | - | 235.84 | 113.77 | |
PB Ratio | 2.49 | 1.89 | 1.52 | 7.49 | 8.51 | 8.89 | |
P/TBV Ratio | 18.04 | 2.74 | 2.00 | 9.16 | 18.70 | 8.89 | |
EV/Sales Ratio | - | - | - | - | 226.70 | 98.28 | |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | - | |
Asset Turnover | - | - | - | - | 0.04 | - | |
Quick Ratio | 1.10 | 3.29 | 3.90 | 7.64 | 4.77 | 11.37 | |
Current Ratio | 1.29 | 3.53 | 4.25 | 8.29 | 5.30 | 12.23 | |
Return on Equity (ROE) | -129.29% | -101.88% | -156.34% | -120.39% | -88.61% | - | |
Return on Assets (ROA) | -71.52% | -56.33% | -87.78% | -116.79% | -48.55% | - | |
Return on Capital (ROIC) | -96.35% | -69.64% | -101.75% | -131.97% | -55.07% | - | |
Earnings Yield | -96.98% | -62.82% | -123.19% | -13.64% | -8.21% | -6.72% | |
FCF Yield | -75.46% | -49.78% | -86.24% | -13.97% | -6.44% | -11.20% | |
Buyback Yield / Dilution | -17.51% | -36.37% | -21.50% | -40.32% | -87.63% | -41.59% | |
Total Shareholder Return | -17.51% | -36.37% | -21.50% | -40.32% | -87.63% | -41.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.